160 related articles for article (PubMed ID: 36717932)
1. Decreased ratios of matrix metalloproteinases to tissue-type inhibitors in cerebrospinal fluid in sporadic and hereditary cerebral amyloid angiopathy.
Vervuurt M; de Kort AM; Jäkel L; Kersten I; Abdo WF; Schreuder FHBM; Rasing I; Terwindt GM; Wermer MJH; Greenberg SM; Klijn CJM; Kuiperij HB; Verbeek MM
Alzheimers Res Ther; 2023 Jan; 15(1):26. PubMed ID: 36717932
[TBL] [Abstract][Full Text] [Related]
2. Decreased Cerebrospinal Fluid Amyloid β 38, 40, 42, and 43 Levels in Sporadic and Hereditary Cerebral Amyloid Angiopathy.
De Kort AM; Kuiperij HB; Marques TM; Jäkel L; van den Berg E; Kersten I; van Berckel-Smit HEP; Duering M; Stoops E; Abdo WF; Rasing I; Voigt S; Koemans EA; Kaushik K; Warren AD; Greenberg SM; Brinkmalm G; Terwindt GM; Wermer MJH; Schreuder FHBM; Klijn CJM; Verbeek MM
Ann Neurol; 2023 Jun; 93(6):1173-1186. PubMed ID: 36707720
[TBL] [Abstract][Full Text] [Related]
3. Plasma amyloid beta 42 is a biomarker for patients with hereditary, but not sporadic, cerebral amyloid angiopathy.
de Kort AM; Kuiperij HB; Jäkel L; Kersten I; Rasing I; van Etten ES; van Rooden S; van Osch MJP; Wermer MJH; Terwindt GM; Schreuder FHBM; Klijn CJM; Verbeek MM
Alzheimers Res Ther; 2023 Jun; 15(1):102. PubMed ID: 37270536
[TBL] [Abstract][Full Text] [Related]
4. Cerebrospinal fluid cytokines and metalloproteinases in cerebral amyloid angiopathy-related inflammation.
Sakai K; Noguchi-Shinohara M; Ikeda T; Hamaguchi T; Ono K; Yamada M
Acta Neurol Scand; 2021 Apr; 143(4):450-457. PubMed ID: 33247941
[TBL] [Abstract][Full Text] [Related]
5. Serum and cerebrospinal fluid neurofilament light chain and glial fibrillary acid protein levels in early and advanced stages of cerebral amyloid Angiopathy.
Rasing I; Voigt S; Koemans EA; de Kort AM; van Harten TW; van Etten ES; van Zwet EW; Stoops E; Francois C; Kuiperij BH; Klijn CJM; Schreuder FHBM; van der Weerd L; van Osch MJP; van Walderveen MAA; Verbeek MM; Terwindt GM; Wermer MJH
Alzheimers Res Ther; 2024 Apr; 16(1):86. PubMed ID: 38654326
[TBL] [Abstract][Full Text] [Related]
6. Neuropsychiatric symptoms with focus on apathy and irritability in sporadic and hereditary cerebral amyloid angiopathy.
Kaushik K; de Kort AM; van Dort R; van der Zwet RGJ; Siegerink B; Voigt S; van Zwet EW; van der Plas MC; Koemans EA; Rasing I; Kessels RPC; Middelkoop HAM; Schreuder FHBM; Klijn CJM; Verbeek MM; Terwindt GM; van Etten ES; Wermer MJH
Alzheimers Res Ther; 2024 Apr; 16(1):74. PubMed ID: 38582898
[TBL] [Abstract][Full Text] [Related]
7. Matrix metalloproteinases and their tissue inhibitors in serum and cerebrospinal fluid of patients with amyotrophic lateral sclerosis.
Niebroj-Dobosz I; Janik P; Sokołowska B; Kwiecinski H
Eur J Neurol; 2010 Feb; 17(2):226-31. PubMed ID: 19796283
[TBL] [Abstract][Full Text] [Related]
8. MMP-7 and TIMP-1, new targets in predicting poor wound healing in apical periodontitis.
Letra A; Ghaneh G; Zhao M; Ray H; Francisconi CF; Garlet GP; Silva RM
J Endod; 2013 Sep; 39(9):1141-6. PubMed ID: 23953287
[TBL] [Abstract][Full Text] [Related]
9. Sex Differences in Onset and Progression of Cerebral Amyloid Angiopathy.
Koemans EA; Castello JP; Rasing I; Abramson JR; Voigt S; Perosa V; van Harten TW; van Zwet EW; Terwindt GM; Gurol ME; Rosand J; Greenberg SM; van Walderveen MAA; Biffi A; Viswanathan A; Wermer MJH
Stroke; 2023 Feb; 54(2):306-314. PubMed ID: 36689586
[TBL] [Abstract][Full Text] [Related]
10. Elevated expression of urokinase plasminogen activator in rodent models and patients with cerebral amyloid angiopathy.
Vervuurt M; Zhu X; Schrader J; de Kort AM; Marques TM; Kersten I; Peters van Ton AM; Abdo WF; Schreuder FHBM; Rasing I; Terwindt GM; Wermer MJH; Greenberg SM; Klijn CJM; Kuiperij HB; Van Nostrand WE; Verbeek MM
Neuropathol Appl Neurobiol; 2022 Aug; 48(5):e12804. PubMed ID: 35266166
[TBL] [Abstract][Full Text] [Related]
11. Temporal Ordering of Biomarkers in Dutch-Type Hereditary Cerebral Amyloid Angiopathy.
Koemans EA; Rasing I; Voigt S; van Harten TW; van der Zwet RGJ; Kaushik K; Schipper MR; van der Weerd N; van Zwet EW; van Etten ES; van Osch MJP; Kuiperij B; Verbeek MM; Terwindt GM; Greenberg SM; van Walderveen MAA; Wermer MJH
Stroke; 2024 Apr; 55(4):954-962. PubMed ID: 38445479
[TBL] [Abstract][Full Text] [Related]
12. Matrix metalloproteinases and tissue inhibitors of metalloproteinases in the aqueous humour of patients with primary angle closure glaucoma - a quantitative study.
Nga AD; Yap SL; Samsudin A; Abdul-Rahman PS; Hashim OH; Mimiwati Z
BMC Ophthalmol; 2014 Mar; 14():33. PubMed ID: 24655889
[TBL] [Abstract][Full Text] [Related]
13. The Use of Serum Matrix Metalloproteinases in Cerebral Amyloid Angiopathy-Related Intracerebral Hemorrhage and Cognitive Impairment.
Xia M; Su Y; Fu J; Xu J; Wang Q; Gao F; Shen Y; Dong Q; Cheng X
J Alzheimers Dis; 2021; 82(3):1159-1170. PubMed ID: 34151802
[TBL] [Abstract][Full Text] [Related]
14. Imbalances between matrix metalloproteinases (MMPs) and tissue inhibitor of metalloproteinases (TIMPs) in maternal serum during preterm labor.
Tency I; Verstraelen H; Kroes I; Holtappels G; Verhasselt B; Vaneechoutte M; Verhelst R; Temmerman M
PLoS One; 2012; 7(11):e49042. PubMed ID: 23145060
[TBL] [Abstract][Full Text] [Related]
15. Imbalanced circulating matrix metalloproteinases in polycystic ovary syndrome.
Gomes VA; Vieira CS; Jacob-Ferreira AL; Belo VA; Soares GM; Fernandes JB; Ferriani RA; Tanus-Santos JE
Mol Cell Biochem; 2011 Jul; 353(1-2):251-7. PubMed ID: 21437624
[TBL] [Abstract][Full Text] [Related]
16. Matrix metalloproteinases and tissue inhibitors of metalloproteinases in sera and tissue of patients with Dupuytren's disease.
Ulrich D; Hrynyschyn K; Pallua N
Plast Reconstr Surg; 2003 Oct; 112(5):1279-86. PubMed ID: 14504511
[TBL] [Abstract][Full Text] [Related]
17. Association of Plasma Matrix Metalloproteinase and Tissue Inhibitors of Matrix Metalloproteinase Levels With Adverse Treatment Outcomes Among Patients With Pulmonary Tuberculosis.
Kumar NP; Moideen K; Nancy A; Viswanathan V; Thiruvengadam K; Sivakumar S; Hissar S; Nair D; Banurekha VV; Kornfeld H; Babu S
JAMA Netw Open; 2020 Dec; 3(12):e2027754. PubMed ID: 33258908
[TBL] [Abstract][Full Text] [Related]
18. Occurrence of matrix metalloproteinases and tissue inhibitors of metalloproteinases in tuberculous pleuritis.
Hoheisel G; Sack U; Hui DS; Huse K; Chan KS; Chan KK; Hartwig K; Schuster E; Scholz GH; Schauer J
Tuberculosis (Edinb); 2001; 81(3):203-9. PubMed ID: 11466032
[TBL] [Abstract][Full Text] [Related]
19. Selected Metal Matrix Metalloproteinases and Tissue Inhibitors of Metalloproteinases as Potential Biomarkers for Tubulointerstitial Fibrosis in Children with Unilateral Hydronephrosis.
Bieniaś B; Sikora P
Dis Markers; 2020; 2020():9520309. PubMed ID: 32670438
[TBL] [Abstract][Full Text] [Related]
20. Cerebrospinal fluid shotgun proteomics identifies distinct proteomic patterns in cerebral amyloid angiopathy rodent models and human patients.
Vervuurt M; Schrader JM; de Kort AM; Kersten I; Wessels HJCT; Klijn CJM; Schreuder FHBM; Kuiperij HB; Gloerich J; Van Nostrand WE; Verbeek MM
Acta Neuropathol Commun; 2024 Jan; 12(1):6. PubMed ID: 38191511
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]